LONG COVID-19

Clinical trials for LONG COVID-19 explained in plain language.

Never miss a new study

Get alerted when new LONG COVID-19 trials appear

Sign up with your email to follow new studies for LONG COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 5 Completed 7

Could anktiva ease long COVID? new trial begins.

Symptom relief Recruiting now

This study tests the safety of a drug called NAI (Anktiva) in 40 adults with Long COVID—symptoms that last after a COVID-19 infection is over. Researchers will monitor side effects and changes in lab results. The goal is to see if the drug is safe enough for further testing.

Matched conditions: LONG COVID-19

Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Symptom relief

Last updated May 13, 2026 15:59 UTC

LONG COVID-19

Get alerted when new LONG COVID-19 trials appear

Could anktiva ease long COVID? new trial begins.